BBC0403 is a selective BRD2 inhibitor with Kds of 7.64 µM and 41.37 µM for BRD2 (BD2) and BRD2 (BD1), respectively. BBC0403 exhibitS higher binding specificity for BRD2 compared to BRD3 and BRD4. BBC0403 has the potential for osteoarthritis (OA) research[1].
Molecular Weight:
382.41
Purity:
98.78
CAS Number:
[2644662-83-7]
Formula:
C21H22N2O5
Target:
Epigenetic Reader Domain
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted